{"transactions":[{"id":830411,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:20:20.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":3249794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"812,448 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030."}],"balance_after":3249794,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":3249794},"source":{"system":"sec-edgar","filing":"0001104659-26-033954","document":"tm269618-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033954/tm269618-1_4seq1.xml","form_type":"4"}},{"id":1379768,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-10-31T01:45:06.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"104,164 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028."}],"balance_after":1250000,"derivative":{"exercise_price":0.13,"expiration_date":"2034-10-28","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001104659-24-112753","document":"tm2427081-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924112753/tm2427081-1_4seq1.xml","form_type":"4"}},{"id":1686703,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Legal Affairs"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:14.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027."}],"balance_after":1000000,"derivative":{"exercise_price":0.21,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-24-001950","document":"tm242134-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001950/tm242134-1_4seq1.xml","form_type":"4"}},{"id":1686702,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Legal Affairs"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:14.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026."}],"balance_after":100000,"derivative":{"exercise_price":0.21,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-001950","document":"tm242134-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001950/tm242134-1_4seq1.xml","form_type":"4"}},{"id":1686701,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":56427,"kind":"person","name":"Blok Tyler","position":1,"cik":"0001990234","reported_name":"Blok Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Legal Affairs"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2024-01-06T02:01:14.000Z","date":"2024-01-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The outstanding option was cancelled in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-001950","document":"tm242134-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465924001950/tm242134-1_4seq1.xml","form_type":"4"}}]}